Rafael Holdings, Inc. Class B RFL 深 滬
已收盤 07-25 16:00:00 美东时间
2.12
+0.010
+0.47%
華盛通- 最 高2.1613
- 今 開2.10
- 成交量 2.52万股
- 最 低 2.10
- 昨 收 2.11
- 總市值 7439.16万
- 52周最高 3.19
- 市盈率 靜 --
- 換手率 0.07%
- 52周最低 1.28
- 委 比 0.00%
- 總股本 3509.04万
- 歷史最高 65.5004
- 量 比 0.39
- 振 幅 2.91%
- 歷史最低 1.2718
- 每 手 1
- 風險率 0.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Rafael Holdings Elects N. Scott Fine as Vice Chairman
Rafael Holdings ( ($RFL) ) has shared an update. On July 14, 2025, Rafael Holdi...
07-18 20:57
Butterfly Gandhimathi Announces Virtual AGM with E-Voting
The latest update is out from Butterfly Gandhimathi Appliances Limited ( ($IN:B...
06-29 03:24
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data
Rafael Holdings announced that its subsidiary Cyclo Therapeutics' 96-week pivotal phase 3 TransportNPC study evaluating intravenous Trappsol® Cyclo™ for the potential treatment of Niemann-Pick Disease Type C1 (NPC1) will continue following a favorable interim analysis by an independent Data Monitoring Committee (DMC) and FDA acceptance of the statistical analysis plan. TrappsolCyclo has shown a favorable safety profile in phase 1, 2, and ongoing ...
06-18 11:00
Rafael Holdings shares are trading lower. The company reported Q3 financial results.
Rafael Holdings shares are trading lower. The company reported Q3 financial res...
06-12 00:49
Rafael Holdings Q3 EPS $(0.19) Up From $(1.36) YoY, Sales $362.00K Up From $336.00K YoY
Rafael Holdings (NYSE:RFL) reported quarterly losses of $(0.19) per share. This is a 86.03 percent increase over losses of $(1.36) per share from the same period last year. The company reported $362.00 thousand in sales
06-11 19:24
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering
Rafael Holdings, Inc. completed a $25 million rights offering, raising $4.007 million through 3.13 million Class B shares at $1.28 each. Howard Jonas, CEO, and affiliates initially holding 32% of shares did not exercise their rights due to a backstop commitment, purchasing unsubscribed shares for $20.99 million. The offering and backstop placement total $24.9 million net proceeds, supporting regulatory efforts and potential launch of Trappsol Cyc...
06-04 20:01
Rafael Holdings Updates Terms Of Rights Offering, Granting 1 Non-Transferable Subscription Right Per Share Or Equivalent Public Warrant Held As Of May 9, 2025, Allowing Holders To Purchase 0.603 Shares Of Class B Common Stock At $1.28 Per Share, With Public Warrant Holders Receiving 0.3525 Rights Per Warrant And Full Rights Granted Per 3 Warrants Held
Rafael Holdings, Inc. (NYSE:RFL, NYSE:RFL) today provided an update to the subscription rights related to its Public Warrants in connection with its previously announced rights offering.Under the rights offering, Rafael
05-21 04:03
Rafael And Cyclo Therapeutics Have Agreed To Combine To Focus Trappsol Cyclo For Niemann-pick Disease Type C1
On consummation of the merger, Rafael will issue Class B shares to Cyclo Therapeutics' shareholders, based on an exchange ratio valuing Cyclo Therapeutics shares at $.95 per share and Rafael Holdings at its cash value
2024-08-22 18:52
基石制药公司获得欧洲监管机构对胆道癌候选药物的孤儿药物指定
12:03 PM EDT, 05/24/2022 (MT Newswires) -- Rafael Holdings' (RFL) Cornerstone P...
2022-05-25 00:04
欧洲药品管理局批准Cornerstone制药公司的CPI-613型®(德维米特)治疗晚期无法切除的胆道癌患者的孤儿药物
Cranbury, NJ, May 24, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc...
2022-05-24 23:05
